Sona Nanotech, an Ontario-based company, has developed a Covid-19 rapid testing product for detection of the virus in individuals without symptoms of illness. The product is an oral fluid-based diagnostics test that uses a small saliva sample to provide quick results within 15 minutes.
The test is a lab-free rapid solution that provides users with an accurate and instant diagnosis of Covid-19. It requires no blood or tissue sample, unlike traditional testing methods. In addition, it is a fully automated process and can be used in an office or at home without the need for a technician or specialist.
Sona Nanotech’s Covid-19 testing kit is also very cost-effective, coming in at a much lower price than traditional tests. The kit uses a process called RT-LAMP, which enables the testing of a wide range of infectious agents at the same time. It is also capable of detecting multiple mutations of the virus, giving it an advantage over other rapid tests.
The company’s testing product has already been approved by Health Canada and is currently undergoing clinical trials for US FDA approval. The clinical trials are being conducted in collaboration with the University of Toronto’s advanced technology laboratory, which is helping to further develop the test’s accuracy.
By providing a symptomless, rapid, and accurate testing product for Covid-19, Sona Nanotech is revolutionizing how individuals can detect the virus. Its innovative product can help save lives by diagnosing individuals in a timely manner and preventing the further spread of the virus. Sona Nanotech is a great example of how innovative technology can be used to address major global health issues.
